We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Handheld Nanopore DNA Sequencer Rapidly Detects Viral Infections in Blood Samples

By LabMedica International staff writers
Posted on 11 Oct 2015
Print article
Image: Close up of the MinION nanopore sequencer (Photo courtesy of Dr. Andrew Kilianski, Edgewood Chemical Biological Center).
Image: Close up of the MinION nanopore sequencer (Photo courtesy of Dr. Andrew Kilianski, Edgewood Chemical Biological Center).
A handheld nanopore DNA sequencer was used to accurately identify and differentiate viruses in patient blood samples with an unprecedented sample-to-answer turnaround time of less than six hours.

The Oxford Nanopore Technologies (Oxford, United Kingdom) MinION nanopore sequencer rapidly determines the sequence of subject DNA through the application of protein nanopore technology. The method is based on a protein channel—only a few nanometers in diameter—through which a single strand of DNA can pass. As the DNA strand passes through the nanopore, it generates a series of characteristic electrical signatures, from which nucleotide bases can be identified, and the sequence of the strand determined. The instrument is powered and operated by a laptop computer via a USB connection.

Investigators at the University of California, San Francisco (USA; www.ucsf.edu) used a MinION instrument to analyze blood samples from four patients for Chikungunya virus (CHIKV), Ebolavirus (EBOV), and Hepatitis C virus (HCV).

They reported that at high titers ranging from 107 to 108 copies per milliliter, reads to EBOV from two patients with acute hemorrhagic fever and CHIKV from an asymptomatic blood donor were detected within 4 to 10 minutes of data acquisition, while lower titer HCV virus (1x105 copies per milliliter) was detected within 40 minutes. Confirmation of results was obtained by sequencing with an Illumina Inc. (San Diego, CA, USA) MiSeq instrument.

Nanopore sequencing is a third-generation sequencing technology that has two key advantages over second-generation technologies—longer reads and the ability to perform real-time sequence analysis. As of mid-2015, the MinION nanopore sequencer was capable of producing at least 100,000 sequences with an average read length of five kilobases, in total producing up to one gigabase of sequence in 24 hours on one flow cell.

In the current study, the investigators presented nanopore sequencing for metagenomic detection of viral pathogens from clinical samples with a sample-to-answer turnaround time of less than six hours. They also introduced MetaPORE, a real-time web-based sequence analysis and visualization tool for pathogen identification from nanopore data.

“To our knowledge, this is the first time that nanopore sequencing has been used for real-time metagenomic detection of pathogens in complex clinical samples in the setting of human infections,” said senior author Dr. Charles Y Chiu, associate professor of laboratory medicine at the University of California, San Francisco. “Unbiased point-of-care testing for pathogens by rapid metagenomic sequencing has the potential to radically transform infectious disease diagnosis in both clinical and public health settings. This point-of-care genomic technology will be particularly attractive in the developing world, where critical resources, including reliable electric power, laboratory space, and computational server capacity, are often severely limited.

The study was published in the September 29, 2015, online edition of the journal Genome Medicine.

Related Links:

Oxford Nanopore Technologies
University of California, San Francisco
Illumina Inc.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.